Counsyl Appoints Chief Financial Officer And General Counsel

The company welcomes industry veterans, Joel Jung and Peter Soparkar, to support growth in its DNA testing business

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Counsyl, a DNA testing and genetic counseling service, today announced two strategic appointments to its executive leadership team:

“We’re thrilled to welcome them to Counsyl and excited about their potential to drive our mission.”

• Joel Jung, Chief Financial Officer

• Peter Soparkar, General Counsel

Joel Jung joins Counsyl with nearly 20 years of experience as an executive in the life sciences industry. Most recently, Joel was the Chief Financial Officer of BioNano Genomics, a privately held company that is developing a new genomic mapping platform. Prior to BioNano, Joel was the Chief Financial Officer and Treasurer of AgraQuest, a privately held biotechnology company, where he played an integral role in the company’s acquisition by Bayer in 2012. Before AgraQuest, Joel was the Chief Financial Officer and Treasurer for the Celera Corporation where he led the financial team in the spinout from the Applera Corporation, listing the company as an independent, publicly traded company. Joel’s experience also includes working at Chiron Corporation for 11 years in several executive financial positions. He began his finance career at Bank of America. Joel earned an MBA from the University of California, Berkeley, Haas School of Business and a B.S. from Purdue University.

Peter Soparkar joins Counsyl from Jazz Pharmaceuticals, where he led the legal team’s operations support and delivered on numerous debt and equity financings and four landmark transactions, including the launched tender-offer of Celator, the acquisitions of Italy-based Gentium, UK based EUSA Pharma, and the acquisition of and inversion into Ireland based Azur Pharma. Prior to Jazz, Peter worked at Latham & Watkins in London and San Francisco, with a practice spanning international and domestic markets, as well as private and public transactions. His deep life-sciences legal experience includes support for development activities, corporate governance, legal and regulatory compliance, public companies and compliant commercial activities. He received a J.D. from New York University and a B.A. from Oberlin College.

“Joel and Peter bring highly relevant, complementary and deep executive perspective to our leadership team,” Counsyl co-founder and CEO, Ramji Srinivasan, said of the new appointments. “We’re thrilled to welcome them to Counsyl and excited about their potential to drive our mission.”

About Counsyl

Counsyl is a DNA testing and genetic counseling service. We're committed to helping patients understand their DNA and how it can inform important health decisions. Whether it’s starting a family or evaluating risk for cancer, Counsyl's DNA tests provide patients with early awareness about genetic conditions, so they can live informed and prepare for the future. Counsyl has screened more than 600,000 patients and served more than 10,000 health care professionals.

For more information, visit www.counsyl.com.

Contacts

Counsyl
Alissa Reiter, 888-268-6795
press@counsyl.com

Back to news